Advent Capital Management’s GSK GSK Stock Holding History

Advent Capital Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-80,000	Closed	-$4M	–	220
2019 Q2	$4M	Buy	+80,000	New	+$4.01M	0.08%	152
2016 Q2	–	Sell	-57,600	Closed	-$3.03M	–	475
2016 Q1	$2.92M	Hold	57,600	–	–	0.04%	257
2015 Q4	$2.97M	Buy	57,600 +36,000	+167%	+$1.83M	0.05%	271
2015 Q3	$1.04M	Sell	21,600 -35,600	-62%	-$1.85M	0.02%	364
2015 Q2	$2.98M	Sell	57,200 -17,181	-23%	-$967K	0.04%	282
2015 Q1	$4.29M	Sell	74,381 -10,381	-12%	-$595K	0.06%	236
2014 Q4	$4.53M	Buy	+84,762	New	+$4.74M	0.07%	247

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Advent Capital Management's GSK Position: Q3 2019 in Review

Advent Capital Management sold out of GSK (GSK) in Q3 2019, closing a stake of 80,000 shares — an estimated $4M sold.

Advent Capital Management first reported a position in GSK in Q4 2014 and held it in 7 quarters. The position peaked at $4.53M in Q4 2014. 806 funds tracked by Wall St. Rank hold GSK as of Q3 2019.

Advent Capital Management reported no remaining GSK position as of Q3 2019 after selling out during the quarter.
Advent Capital Management sold 80,000 GSK shares in Q3 2019, an estimated $4M.
Advent Capital Management first reported a position in GSK in Q4 2014 and held it in 7 quarters.
Advent Capital Management's GSK position peaked at $4.53M in Q4 2014.
806 funds tracked by Wall St. Rank held GSK as of Q3 2019.

Based on Advent Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.